Core transcription factors, Oct4, Sox2 and Nanog, individually form complexes with nucleophosmin (Npm1) to control embryonic stem (ES) cell fate determination

Aging

Volumn 2, Issue 11, 2010, Pages 815-822

  Johansson, Helena ^a   Simonsson, Stina ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Es cells; Nanog; Npm1; Oct4; Sox2; Tpt1

Indexed keywords

HOMEODOMAIN PROTEIN; MULTIPROTEIN COMPLEX; NANOG PROTEIN, MOUSE; NUCLEAR PROTEIN; NUCLEOPHOSMIN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, MOUSE; SMALL INTERFERING RNA; SOX2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN, P23; TUMOR MARKER;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CYTOLOGY; EMBRYONIC STEM CELL; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN ANALYSIS;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HOMEODOMAIN PROTEINS; MICE; MULTIPROTEIN COMPLEXES; NUCLEAR PROTEINS; OCTAMER TRANSCRIPTION FACTOR-3; PROTEIN INTERACTION MAPPING; RNA, SMALL INTERFERING; SOXB1 TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952641547     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100222     Document Type: Article

References (32)

1. Chen L. and Daley GQ. Molecular basis of pluripotency. Hum Mol Genet. 2008; 17: R23-27.
2. Takahashi K and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663-676.
3. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark AT, and Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A. 2008; 105: 2883-2888.
4. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, and Daley GQ. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008; 451: 141-146.
5. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131: 861-872.
6. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, and Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318: 1917 -1920.
7. Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM, Khalil A, Rheinwald JG, and Hochedlinger K. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature. 2009; 460: 1145-1148.
8. Elliott ST, Crider DG, Garnham CP, Boheler KR, and Van Eyk JE. Two-dimensional gel electrophoresis database of murine R1 embryonic stem cells. Proteomics. 2004; 4: 3813-3832.
9. Richards M, Tan SP, Tan JH, Chan WK, and Bongso A. The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells. 2004; 22: 51-64.
10. Okuwaki, M. The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein. J Biochem. 2008; 143: 441-448.
11. Kondo T, Minamino N, Nagamura-Inoue T, Matsumoto M, Taniguchi T, and Tanaka N. Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene. 1997; 15: 1275-1281.
12. Inouye CJ and Seto E. Relief of YY1-induced transcriptional repression by protein-protein interaction with the nucleolar phosphoprotein B23. J Biol Chem. 1994; 269: 6506-6510.
13. Swaminathan V, Kishore AH, Febitha KK, and Kundu TK. Human histone chaperone nucleophosmin enhances acetylationdependent chromatin transcription. Mol Cell Biol. 2005; 25: 7534-7545.
14. Johansson H, Vizlin-Hodzic D, Simonsson T, and Simonsson S. Translationally controlled tumor protein interacts with nucleophosmin during mitosis in ES cells. Cell Cycle. 2010; 9: 2160-2169.
15. Tani T, Shimada H, Kato Y, and Tsunoda Y. Bovine oocytes with the potential to reprogram somatic cell nuclei have a unique 23-kDa protein, phosphorylated transcriptionally controlled tumor protein (TCTP). Cloning Stem Cells. 2007; 9: 267-280.
16. Li Z, Boone D, and Hann SR. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation. Proc Natl Acad Sci U S A. 2008; 105: 18794- 18799.
17. Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius KJ, Jarvius J, Wester K, Hydbring P, Bahram F, Larsson LG, and Landegren U. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods. 2006; 3: 995-1000.
18. Koziol MJ, Garrett N, and Gurdon JB. Tpt1 activates transcription of oct4 and nanog in transplanted somatic nuclei. Curr Biol. 2007; 17: 801-807.
19. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, and Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 1998; 95: 379-391.
20. Wang, D. and Gao, L. Proteomic analysis of neural differentiation of mouse embryonic stem cells. Proteomics. 2005; 5: 4414-4426.
21. Koide Y, Kiyota T, Tonganunt M, Pinkaew D, Liu Z, Kato Y, Hutadilok-Towatana N, Phongdara A, and Fujise K. Embryonic lethality of fortilin-null mutant mice by BMP-pathway overactivation. Biochim Biophys Acta. 2009; 1790: 326-338.
22. Chen SH, Wu PS, Chou CH, Yan YT, Liu H, Weng SY, and Yang- Yen HF. A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner. Mol Biol Cell. 2007; 18: 2525-2532.
23. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, and Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282: 1145- 1147.
24. Niwa H, Miyazaki J, and Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000; 24: 372-376.
25. Wang BB, Lu R, Wang WC, and Jin Y. Inducible and reversible suppression of Npm1 gene expression using stably integrated small interfering RNA vector in mouse embryonic stem cells. Biochem Biophys Res Commun. 2006; 347: 1129-1137.
26. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, and Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 2003; 17: 126-140.
27. Qing Y, Yingmao G, Lujun B, and Shaoling L. Role of Npm1 in proliferation, apoptosis and differentiation of neural stem cells. J Neurol Sci. 2008; 266: 131-137.
28. Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, and Pandolfi PP. Role of nucleophosmin in embryonic development and tumorigenesis. Nature. 2005; 437: 147-153.
29. Singh AM, Hamazaki T, Hankowski KE, and Terada N. A heterogeneous expression pattern for Nanog in embryonic stem cells. Stem Cells. 2007; 25: 2534-2542.
30. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, and Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 2003; 113: 631- 642.
31. Zhang X, Neganova I, Przyborski S, Yang C, Cooke M, Atkinson SP, Anyfantis G, Fenyk S, Keith WN, Hoare SF, Hughes O, Strachan T, Stojkovic M et al. A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A. J Cell Biol. 2009; 184: 67-82.
32. Murano K, Okuwaki M, Hisaoka M, and Nagata K. Transcription regulation of the rRNA gene by a multifunctional nucleolar protein, B23/nucleophosmin, through its histone chaperone activity. Mol Cell Biol. 2008; 28: 3114-3126.